SAFETY AND TOLERABILITY OF BAZEDOXIFENE IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS OF A 5-YEAR, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL

被引：0
|
作者：
Kendler, D. L. [1 ]
Chines, A. A. [3 ]
Lips, P. [4 ]
Kaufman, J. M. [5 ]
Levine, A. B. [3 ]
Mairon, N. [6 ]
Codreanu, C. [7 ]
Felsenberg, D. [8 ]
Brown, J. P.
De Villiers, T. J. [2 ,9 ,10 ]
机构：
[1] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[2] Univ Laval, Res Ctr, CHUL, Quebec City, PQ, Canada
[3] Pfizer Inc, Collegeville, PA USA
[4] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[5] Ghent Univ Hosp, B-9000 Ghent, Belgium
[6] Wyeth Ayerst Res, Paris, France
[7] Ctr Rheumat Dis, Bucharest, Romania
[8] Charite, Ctr Muscle & Bone Res, D-13353 Berlin, Germany
[9] Panorama MediClin, Cape Town, South Africa
[10] Univ Stellenbosch, Cape Town, South Africa
来源：
OSTEOPOROSIS INTERNATIONAL | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：339 / 340
页数：2
相关论文
共 50 条
  • [21] Final 5-Year Safety and Efficacy Results Of a Phase 3, Randomized, Placebo-Controlled Trial Of Golimumab In Methotrexate-naive Patients With Rheumatoid Arthritis
    Emery, Paul
    Fleischmann, Roy M.
    Strusberg, Ingrid
    Durez, Patrick
    Nash, Peter
    Amante, Eric
    Churchill, Melvin A.
    Park, Won
    Pons-Estel, Bernardo
    Han, Chenglong
    Gathany, Timothy A.
    Zhou, Yiying
    Xu, Stephen
    Hsia, Elizabeth C.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S188 - S189
  • [22] FINAL 5-YEAR SAFETY AND EFFICACY RESULTS OF A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF GOLIMUMAB IN METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS
    Emery, Paul
    Fleischmann, Roy M.
    Strusberg, Ingrid
    Durez, Patrick
    Nash, Peter
    Amante, Eric
    Churchill, Melvin
    Park, W.
    Pons-Estel, Bernardo
    Han, Chenglong
    Gathany, Tim
    Zhou, Yiying
    Xu, Stephen
    Hsia, Elizabeth C.
    RHEUMATOLOGY, 2014, 53 : 93 - 93
  • [23] EFFECTS OF BAZEDOXIFENE/CONJUGATED ESTROGENS ON METABOLIC PARAMETERS: A RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL IN POSTMENOPAUSAL WOMEN.
    Taylor, H. S.
    Mirkin, S.
    Chines, A.
    FERTILITY AND STERILITY, 2010, 94 (04) : S44 - S44
  • [24] Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial
    Silverman, Stuart L.
    Christiansen, Claus
    Genant, Harry K.
    Vukicevic, Slobodan
    Zanchetta, Jose R.
    de Villiers, Tobie J.
    Constantine, Ginger D.
    Chines, Arkadi A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 (12) : 1923 - 1934
  • [25] Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: Results from a 3-year, randomized, placebo- and active-controlled clinical trial
    Adachi, J. D.
    Silverman, S. L.
    Christiansen, C.
    Genant, H.
    Zanchetta, J. R.
    Valter, I.
    de Villiers, T. J.
    Constantine, G.
    Chines, A. A.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) : 1190 - 1190
  • [26] Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: Results from a 3-year, randomized, placebo- and active-controlled clinical trial
    Genant, H. K.
    Silverman, S. L.
    Christiansen, C.
    Zanchetta, J. R.
    Valter, I.
    de Villiers, T. J.
    Constantine, G.
    Chines, A. A.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S52 - S52
  • [27] Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: Results from a 3-year, randomized, placebo- and active-controlled clinical trial
    Silverman, S. L.
    Christiansen, C.
    Genant, H. K.
    Zanchetta, J. R.
    Valter, I.
    de Villiers, T. J.
    Constantine, G.
    Chines, A. A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S58 - S58
  • [28] Randomized placebo-controlled trial of brisk walking in the prevention of postmenopausal osteoporosis
    Ebrahim, S
    Thompson, PW
    Baskaran, V
    Evans, K
    AGE AND AGEING, 1997, 26 (04) : 253 - 260
  • [29] Effects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With Alendronate: A Randomized Placebo-Controlled Trial
    Bonnick, Sydney
    De Villiers, Tobias
    Odio, Alberto
    Palacios, Santiago
    Chapurlat, Roland
    DaSilva, Carolyn
    Scott, Boyd B.
    De Tilleghem, Celine Le Bailly
    Leung, Albert T.
    Gurner, Deborah
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (12): : 4727 - 4735
  • [30] Final 5-Year Safety and Efficacy Results Of a Phase 3, Randomized Placebo-Controlled Trial Of Golimumab In Patients With Active Rheumatoid Arthritis Despite Prior Treatment With Methotrexate
    Keystone, Edward
    Genovese, Mark C.
    Hall, Stephen
    Miranda, Pedro
    Bae, Sang-Cheol
    Han, Chenglong
    Gathany, Timothy A.
    Zhou, Yiying
    Xu, Stephen
    Hsia, Elizabeth C.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S597 - S598
12345